메뉴 건너뛰기




Volumn 7, Issue 1, 2013, Pages 167-175

Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects

Author keywords

Adolescence; Adverse effects; Autism; Childhood; Intellectual disability; Meta analysis; Second generation antipsychotics

Indexed keywords

ARIPIPRAZOLE; PLACEBO; RISPERIDONE;

EID: 84865984572     PISSN: 17509467     EISSN: 18780237     Source Type: Journal    
DOI: 10.1016/j.rasd.2012.08.001     Document Type: Article
Times cited : (41)

References (36)
  • 3
    • 77956455081 scopus 로고    scopus 로고
    • Surveillance of metabolic syndrome, hyperprolactinemia and cardiac side effects in children and adolescent treated with antipsychotic. Actuality and recommendations
    • O. Bonnot, R. Inaoui, C. Lloret, and D. Cohen Surveillance of metabolic syndrome, hyperprolactinemia and cardiac side effects in children and adolescent treated with antipsychotic. Actuality and recommendations Neuropsychiatrie de l'Enfance et de l'adolescence 58 2010 431 438
    • (2010) Neuropsychiatrie de l'Enfance et de l'Adolescence , vol.58 , pp. 431-438
    • Bonnot, O.1    Inaoui, R.2    Lloret, C.3    Cohen, D.4
  • 4
    • 79955153530 scopus 로고    scopus 로고
    • Children and adolescents with severe mental illness need vitamin D supplementation regardless of disease or treatment
    • O. Bonnot, R. Inaoui, and M. Raffin-Viard Children and adolescents with severe mental illness need vitamin D supplementation regardless of disease or treatment Journal of Child and Adolescent Psychopharmacology 21 2011 157 161
    • (2011) Journal of Child and Adolescent Psychopharmacology , vol.21 , pp. 157-161
    • Bonnot, O.1    Inaoui, R.2    Raffin-Viard, M.3
  • 5
    • 84870435837 scopus 로고    scopus 로고
    • BUGS Accessed 28.07.10
    • BUGS The BUGS project 1996-2008 http://www.mrc-bsu.cam.ac.uk/bugs/ winbugs/contents.shtml Accessed 28.07.10
    • (1996) The BUGS Project
  • 6
    • 0035002882 scopus 로고    scopus 로고
    • A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities
    • J.K. Buitelaar, R.J. van der Gaag, P. Cohen-Kettenis, and C.T. Melman A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities Journal of Clinical Psychiatry 62 2001 239 248 (Pubitemid 32428762)
    • (2001) Journal of Clinical Psychiatry , vol.62 , Issue.4 , pp. 239-248
    • Buitelaar, J.K.1    Van Der Gaag, R.J.2    Cohen-Kettenis, P.3    Melman, C.T.M.4
  • 7
    • 26944454062 scopus 로고    scopus 로고
    • Simultaneous comparison of multiple treatments: Combining direct and indirect evidence
    • D. Caldwell, A. Ades, and J. Higgins Simultaneous comparison of multiple treatments: Combining direct and indirect evidence British Medical Journal 331 7521 2005 897 900 (Pubitemid 41502718)
    • (2005) British Medical Journal , vol.331 , Issue.7521 , pp. 897-900
    • Caldwell, D.M.1    Ades, A.E.2    Higgins, J.P.T.3
  • 10
    • 70350738289 scopus 로고    scopus 로고
    • Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
    • C.U. Correll, P. Manu, and V. Olshanskiy Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents The Journal of the American Medical Association 302 2009 1765 1773
    • (2009) The Journal of the American Medical Association , vol.302 , pp. 1765-1773
    • Correll, C.U.1    Manu, P.2    Olshanskiy, V.3
  • 12
    • 77952319138 scopus 로고    scopus 로고
    • Double-blind maintenance safety and effectiveness findings from the treatment of early-onset schizophrenia spectrum (TEOSS) study
    • R.L. Findling, J.L. Johnson, and J. McLellan Double-blind maintenance safety and effectiveness findings from the treatment of early-onset schizophrenia spectrum (TEOSS) study Journal of the American Academy of Child and Adolescent Psychiatry 49 2010 583 594
    • (2010) Journal of the American Academy of Child and Adolescent Psychiatry , vol.49 , pp. 583-594
    • Findling, R.L.1    Johnson, J.L.2    McLellan, J.3
  • 14
    • 72849134437 scopus 로고    scopus 로고
    • Acute treatment of pediatric bipolar i disorder, manic or mixed episode, with aripiprazole: A randomized, double-blind, placebo-controlled study
    • R.L. Findling, M. Nyilas, and R.A. Forbes Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: A randomized, double-blind, placebo-controlled study Journal of Clinical Psychiatry 70 2009 1441 1451
    • (2009) Journal of Clinical Psychiatry , vol.70 , pp. 1441-1451
    • Findling, R.L.1    Nyilas, M.2    Forbes, R.A.3
  • 15
    • 55749106241 scopus 로고    scopus 로고
    • A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia
    • R.L. Findling, A. Robb, and M. Nyilas A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia The American Journal of Psychiatry 165 2008 1432 1441
    • (2008) The American Journal of Psychiatry , vol.165 , pp. 1432-1441
    • Findling, R.L.1    Robb, A.2    Nyilas, M.3
  • 19
    • 70350536654 scopus 로고    scopus 로고
    • Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: A randomized, double-blind, placebo-controlled study
    • M. Haas, M.P. Delbello, and G. Pandina Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: A randomized, double-blind, placebo-controlled study Bipolar Disorders 11 2009 687 700
    • (2009) Bipolar Disorders , vol.11 , pp. 687-700
    • Haas, M.1    Delbello, M.P.2    Pandina, G.3
  • 20
    • 70350546566 scopus 로고    scopus 로고
    • A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia
    • M. Haas, A.S. Unis, and J. Armenteros A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia Journal of Child and Adolescent Psychopharmacology 19 2009 611 621
    • (2009) Journal of Child and Adolescent Psychopharmacology , vol.19 , pp. 611-621
    • Haas, M.1    Unis, A.S.2    Armenteros, J.3
  • 21
    • 5044221416 scopus 로고    scopus 로고
    • Combination of direct and indirect evidence in mixed treatment comparisons
    • DOI 10.1002/sim.1875
    • G. Lu, and A.E. Ades Combination of direct and indirect evidence in mixed treatment comparisons Statistics in Medicine 23 2004 3105 3124 (Pubitemid 39334902)
    • (2004) Statistics in Medicine , vol.23 , Issue.20 , pp. 3105-3124
    • Lu, G.1    Ades, A.E.2
  • 22
    • 71449095638 scopus 로고    scopus 로고
    • A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder
    • R.N. Marcus, R. Owen, and L. Kamen A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder Journal of the American Academy of Child and Adolescent Psychiatry 48 2009 1110 1119
    • (2009) Journal of the American Academy of Child and Adolescent Psychiatry , vol.48 , pp. 1110-1119
    • Marcus, R.N.1    Owen, R.2    Kamen, L.3
  • 23
    • 77957350894 scopus 로고    scopus 로고
    • Psychotropic drug efficacy and side effects for persons with autism spectrum disorders
    • J.L. Matson, and J.A. Hess Psychotropic drug efficacy and side effects for persons with autism spectrum disorders Research in Autism Spectrum Disorders 5 2011 230 236
    • (2011) Research in Autism Spectrum Disorders , vol.5 , pp. 230-236
    • Matson, J.L.1    Hess, J.A.2
  • 26
    • 71949121464 scopus 로고    scopus 로고
    • Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder
    • R. Owen, L. Sikich, and R.N. Marcus Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder Pediatrics 124 2009 1533 1540
    • (2009) Pediatrics , vol.124 , pp. 1533-1540
    • Owen, R.1    Sikich, L.2    Marcus, R.N.3
  • 28
    • 41149087694 scopus 로고    scopus 로고
    • CODA: Convergence diagnosis and output analysis for MCMC
    • M. Plummer, N. Best, K. Cowles, and K. Vines CODA: Convergence diagnosis and output analysis for MCMC R News 6 2006 7 11
    • (2006) R News , vol.6 , pp. 7-11
    • Plummer, M.1    Best, N.2    Cowles, K.3    Vines, K.4
  • 31
    • 0036682267 scopus 로고    scopus 로고
    • Risperidone in children with autism and serious behavioral problems
    • Units In Pediatric Psychopharmacology Autism Network
    • Research Units in Pediatric Psychopharmacology Autism Network Risperidone in children with autism and serious behavioral problems New England Journal of Medicine 347 2002 314 321
    • (2002) New England Journal of Medicine , vol.347 , pp. 314-321
  • 32
    • 16644370679 scopus 로고    scopus 로고
    • Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders
    • S. Shea, A. Turgay, and A. Carroll Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders Pediatrics 114 2004 e634 e641
    • (2004) Pediatrics , vol.114
    • Shea, S.1    Turgay, A.2    Carroll, A.3
  • 33
    • 55749083565 scopus 로고    scopus 로고
    • Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: Findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study
    • L. Sikich, J.A. Frazier, and J. McClellan Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: Findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study The American Journal of Psychiatry 165 2008 1420 1431
    • (2008) The American Journal of Psychiatry , vol.165 , pp. 1420-1431
    • Sikich, L.1    Frazier, J.A.2    McClellan, J.3
  • 36
    • 79959982267 scopus 로고    scopus 로고
    • Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 Receptors
    • Y. Tadori, R.A. Forbes, R.D. McQuade, and T. Kikuchi Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 Receptors European Journal of Pharmacology 666 2011 43 52
    • (2011) European Journal of Pharmacology , vol.666 , pp. 43-52
    • Tadori, Y.1    Forbes, R.A.2    McQuade, R.D.3    Kikuchi, T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.